The Immunologic Profiles of Kawasaki Disease Triggered by Mycoplasma pneumoniae Infection

References

• Poddighe D, Demirkaya E, Sazonov V, Romano M. Mycoplasma pneumoniae infections and primary immune deficiencies. Int J Clin Pract. 2022;2022:6343818. doi:10.1155/2022/6343818.
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Sugino N, Namba T, Tamai K, Nakamura K, Nakamura M, Kageyama M, Yorifuji T, Bonno M. Neonatal sepsis and Kawasaki disease. Eur J Pediatr. 2022;181(8):2927–33. doi:10.1007/s00431-022-04501-z.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Yadav S, Maheshwari A, Mahto D, Divya K, Ackshaya R, Meena H, Shakya S, Kumar V. Profile of children with Kawasaki disease associated with tropical infections. Indian J Pediatr. 2022;89(8):759–64. doi:10.1007/s12098-021-03953-9.
   PubMed Web of Science ®Google Scholar
• Shang XP, Wu JG, Cheng Y, Hu HB. Epidemiology and clinical characteristics of Henoch-Schönlein purpura associated with Mycoplasma pneumoniae infection in 131 children in Hubei province, China. Mediterr J Hematol Infect Dis. 2021;13(1):e2021037. doi:10.4084/MJHID.2021.037.
   PubMedGoogle Scholar
• Lan Y, Li S, Yang D, Zhou J, Wang Y, Wang J, Xu Y, Chen Z. Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia: A retrospective study. Medicine. 2020;99(19):e19987. doi:10.1097/MD.0000000000019987.
   PubMed Web of Science ®Google Scholar
• Tang Y, Gao X, Shen J, Sun L, Yan W. Epidemiological and clinical characteristics of Kawasaki disease and factors associated with coronary artery abnormalities in East China: nine years experience. J Trop Pediatr. 2016;62(2):86–93. doi:10.1093/tropej/fmv077.
   PubMed Web of Science ®Google Scholar
• Tang Y, Yan W, Sun L, Huang J, Qian W, Hou M, Lv H. Kawasaki disease associated with Mycoplasma pneumoniae. Ital J Pediatr. 2016;42(1):83. doi:10.1186/s13052-016-0292-1.
   PubMedGoogle Scholar
• Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708–33. doi:10.1542/peds.2004-2182.
   PubMed Web of Science ®Google Scholar
• Respiratory Branch of Chinese Pediatric Society of Chinese Medical Association. Expert consensus on diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children. Chin J Appl Clin Pediatr. 2015;17:1304–8.
   Google Scholar
• Yang J, Hooper WC, Phillips DJ, Talkington DF. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev. 2004;15(2–3):157–68. doi:10.1016/j.cytogfr.2004.01.001.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Yang TT, He T, et al. Epidemiological and clinical features of Kawasaki disease in a single center from 2012 to 2016. Chin J Evid Based Pediatr. 2018;13(6):427–33.
   Google Scholar
• Wang XC, Cai WW, Jia CS. Clinical analysis of Kawasaki disease complicating with infection: 261 cases. Chin J Obstet Gynecol Pediatr. 2012;8(1):32–5.
   Google Scholar
• Rhim JW, Kang HM, Han JW, Lee KY. A presumed etiology of Kawasaki disease based on epidemiological comparison with infectious or immune-mediated diseases. Front Pediatr. 2019;7:202. doi:10.3389/fped.2019.00202.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu JG, Cheng Y, Hu HB. Epidemiology and clinical characteristics of Henoch-Schönlein purpura associated with streptococcal infection in 217 children in Hubei province, China. Fetal Pediatr Pathol. 2022;41(6):954–61.
   PubMed Web of Science ®Google Scholar
• Hu HB, Wu JG, Cheng Y, Li JJ. Epidemiology and clinical characteristics of Henoch-Schönlein purpura associated with Epstein-Barr virus infection. Mediterr J Hematol Infect Dis. 2021;13(1):e2021064. doi:10.4084/MJHID.2021.064.
   PubMedGoogle Scholar
• Huang Y-S, Liu X-P, Xia H-B, Cui L-N, Lang X-L, Liu C-Y, Huang W-D, Zhang J-Y, Liu X, Kuo H-C, et al. Complement 3 and the prognostic nutritional index distinguish Kawasaki disease from other fever illness with a nomogram. Children. 2021;8(9):825. doi:10.3390/children8090825.
   PubMedGoogle Scholar
• Zhang L, Song Q-F, Jin J-J, Huang P, Wang Z-P, Xie X-F, Gu X-Q, Gao X-J, Jia H-L. Differential protein analysis of serum exosomes post-intravenous immunoglobulin therapy in patients with Kawasaki disease. Cardiol Young. 2017;27(9):1786–96. doi:10.1017/S1047951117001433.
   PubMed Web of Science ®Google Scholar
• Mi YM, Qi Q, Zhang L, Wang XF, Chen ZM, Hua CZ. Assessment of serum sialic acid correlated with C3 in children with Mycoplasma pneumoniae pneumonia. J Clin Lab Anal. 2020;34(3):e23078. doi:10.1002/jcla.23078.
   PubMed Web of Science ®Google Scholar
• Liu D, Song M, Jing F, Liu B, Yi Q. Diagnostic value of immune-related genes in Kawasaki disease. Front Genet. 2021;12:763496.
   PubMed Web of Science ®Google Scholar
• Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, Singh-Grewal D, Bharath S, Sajjan S, Bayry J, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol. 2021;17(12):731–48. doi:10.1038/s41584-021-00709-9.
   PubMed Web of Science ®Google Scholar
• Nie H, Wang S, Wu Q, Xue D, Zhou W. Five immune-gene-signatures participate in the development and pathogenesis of Kawasaki disease. Immun Inflamm Dis. 2021;9(1):157–66. doi:10.1002/iid3.373.
   PubMed Web of Science ®Google Scholar
• Shio MT, Hassan GS, Shah WA, Nadiri A, El Fakhry Y, Li H, Mourad W. Coexpression of TLR2 or TLR4 with HLA-DR potentiates the superantigenic activities of Mycoplasma arthritidis-derived mitogen. J Immunol. 2014;192(6):2543–50. doi:10.4049/jimmunol.1300591.
   PubMed Web of Science ®Google Scholar
• Liu L, Chen H, Brecher MB, Li Z, Wei B, Nandi B, Zhang J, Ling H, Winslow G, Braun J, et al. Pfit is a structurally novel Crohn’s disease-associated superantigen. PLoS Pathog. 2013;9(12):e1003837. doi:10.1371/journal.ppat.1003837.
   PubMed Web of Science ®Google Scholar
• Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM. Superantigens: the good, the bad, and the ugly. Exp Biol Med. 2001;226(3):164–76. doi:10.1177/153537020122600303.
   PubMed Web of Science ®Google Scholar
• Lee SB, Kim YH, Hyun MC, Kim YH, Kim HS, Lee YH. T-helper cytokine profiles in patients with Kawasaki disease. Korean Circ J. 2015;45(6):516–21. doi:10.4070/kcj.2015.45.6.516.
   PubMed Web of Science ®Google Scholar
• Ebrahim M, Gabay M, Rivas-Chacon RF. Evidence of acute Mycoplasma infection in a patient with incomplete and atypical Kawasaki disease: a case report. Case Rep Med. 2011;2011:606920. doi:10.1155/2011/606920.
   PubMedGoogle Scholar
• Fengyong Z, Zhixiang F, Jiajia P, Qin L, Min Q, Guoliang W, Ziyan Z. Increased CD8+ T cells in patients with Henoch-Schonlein purpura nephritis exhibit suppressive immune activity. Immunol Lett. 2022;250:23–8. doi:10.1016/j.imlet.2022.09.003.
   PubMed Web of Science ®Google Scholar
• Chang H, Zhang QY, Lin Y, Cheng N, Zhang SQ. Correlation of TLR2 and TLR4 expressions in peripheral blood mononuclear cells to Th1- and Th2-type immune responses in children with henochschönlein purpura. Int J Clin Exp Med. 2015;8(8):13532–13539.
   PubMed Web of Science ®Google Scholar
• Li Y, Sui X, Zhu H, Xu Y, Huang L, Xu Y, Han Y, Feng X, Qin C. Histopathological and immunological changes during the acute and recovery phase in Henoch-Schönlein purpura rabbit model. Arch Dermatol Res. 2017;309(1):21–30. doi:10.1007/s00403-016-1694-z.
   PubMed Web of Science ®Google Scholar
• Brehm MA, Daniels KA, Welsh RM. Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells. J Immunol. 2005;175(8):5043–9. doi:10.4049/jimmunol.175.8.5043.
   PubMed Web of Science ®Google Scholar
• Ha TS. The role of tumor necrosis factor-alpha in Henoch-Schonlein purpura. Pediatr Nephrol. 2005;20(2):149–53. doi:10.1007/s00467-004-1726-3.
   PubMed Web of Science ®Google Scholar
• Murthy AK, Li W, Chaganty BKR, Kamalakaran S, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP. Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun. 2011;79(7):2928–35. doi:10.1128/IAI.05022-11.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang W, Zhang Z, Ma X, Sang Y, Wang J, Xu G, Feng Q, Zhao S. Serum amyloid a, C-reactive protein, and procalcitonin levels in children with Mycoplasma pneumoniae infection. J Clin Lab Anal. 2022;36(3):e24265.
   PubMed Web of Science ®Google Scholar
• Xu X, Sheng Y, Yang L, Zhou H, Tang L, Du L. Immunological features of pediatric interstitial pneumonia due to Mycoplasma pneumoniae. Front Pediatr. 2021;9:651487.
   PubMed Web of Science ®Google Scholar